1. Home
  2. SR vs IOVA Comparison

SR vs IOVA Comparison

Compare SR & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spire Inc.

SR

Spire Inc.

HOLD

Current Price

$86.89

Market Cap

5.1B

Sector

Utilities

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.65

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SR
IOVA
Founded
1857
2007
Country
United States
United States
Employees
3497
N/A
Industry
Oil/Gas Transmission
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
1.6B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
SR
IOVA
Price
$86.89
$3.65
Analyst Decision
Buy
Buy
Analyst Count
9
10
Target Price
$91.33
$9.00
AVG Volume (30 Days)
329.1K
13.7M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
3.68%
N/A
EPS Growth
N/A
14.84
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.81
$47.74
Revenue Next Year
$2.31
$40.31
P/E Ratio
$19.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$71.24
$1.67
52 Week High
$95.31
$5.63

Technical Indicators

Market Signals
Indicator
SR
IOVA
Relative Strength Index (RSI) 42.63 53.12
Support Level $84.61 $2.05
Resistance Level $92.20 $4.27
Average True Range (ATR) 1.87 0.27
MACD 0.04 -0.00
Stochastic Oscillator 35.34 47.70

Price Performance

Historical Comparison
SR
IOVA

About SR Spire Inc.

Spire Inc. is the holding company for Spire Missouri, Spire Alabama, other gas utilities, and gas-related businesses, focused on growing organically, investing in infrastructure, and advancing through innovation. Its three segments are Gas Utility, Gas Marketing, and Midstream. The Gas Utility segment is the core business and includes Spire Missouri, Spire Alabama, and Spire EnergySouth. The Gas Marketing segment includes Spire Marketing, which provides non-regulated natural gas services across the U.S. The Midstream segment includes Spire Storage, Spire STL Pipeline, and Spire MoGas Pipeline. The majority of revenue comes from Gas Utility.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: